Clinical Trial Update: A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from Aldeyra Therapeutics reports completion of a study evaluating safety and efficacy in subjects with alcoholic hepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• Aldeyra Therapeutics investigational therapy

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Alcohol Hepatitis | Phase 2 | Status: COMPLETED